| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | -0.0064 | 0.9 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | 0.0054 | 0.9 |
| mRNA | ZM-447439 | GDSC1000 | pan-cancer | AAC | 0.0066 | 0.9 |
| mRNA | KIN001-236 | GDSC1000 | pan-cancer | AAC | 0.006 | 0.9 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.0055 | 0.9 |
| mRNA | spautin-1 | CTRPv2 | pan-cancer | AAC | 0.0063 | 0.9 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | -0.0057 | 0.9 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | -0.0063 | 0.9 |
| mRNA | PF-543 | CTRPv2 | pan-cancer | AAC | -0.0062 | 0.9 |
| mRNA | selumetinib:piperlongumine (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0058 | 0.9 |